Correlates of placebo response in the treatment of sexual dysfunction in women: A preliminary report

Journal of Sexual Medicine

Volumn 4, Issue 5, 2007, Pages 1345-1351

  Bradford, Andrea ^a   Meston, Cindy ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

Clinical Trial; Female Sexual Dysfunction; Placebo

Indexed keywords

ANTIDEPRESSANT AGENT; PLACEBO; VASOACTIVE AGENT;

ADULT; AGE DISTRIBUTION; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA ANALYSIS; DISEASE SEVERITY; DRUG RESPONSE; FEMALE; FEMALE SEXUAL DYSFUNCTION; HUMAN; MARRIAGE; MENTAL DISEASE; NONPARAMETRIC TEST; ORGASM DISORDER; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SELF REPORT; SEXUAL AROUSAL DISORDER; SEXUAL FUNCTION; TREATMENT DURATION;

EID: 34548307186     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2007.00578.x     Document Type: Article

References (18)

1. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: Prevalence and predictors. JAMA 1999;281:537-44.
2. Basson R, McInnes R, Smith MD, Hodgson G, Koppiker N. Efficacy and safety of sildenafil citrate in women with sexual dysfunction associated with female sexual arousal disorder. J Womens Health Gend Based Med 2002;11:367-77.
3. Berman JR, Berman LA, Toler SM, Gill J, Haughie S. Safety and efficacy of sildenafil citrate for the treatment of female sexual arousal disorder: A double-blind, placebo controlled study. J Urol 2003;170:2333-38.
4. Martin DJ, Garske JP, Davis MK. Relation of the therapeutic alliance with outcome and other variables: A meta-analytic review. J Consult Clin Psychol 2000;68:438-50.
5. Stewart-Williams S. The placebo puzzle: Putting together the pieces. Health Psychol 2004;23:198-206.
6. Goldstein I, Fisher WA, Sand M, Rosen RC, Mollen M, Brock G, Karlin G, Pommerville P, Bangerter K, Bandel TJ, Derogatis LR. Women's sexual function improves when partners are administered vardenafil for erectile dysfunction: A prospective, randomized, double-blind, placebo-controlled trial. J Sex Med 2005;2:819-32.
7. Bootzin RR, Caspi O. Explanatory mechanisms for placebo effects: Cognition, personality and social learning. In: Guess HA, Kleinman A, Kusek JW, Engel LW, eds. The science of placebo: Toward an interdisciplinary agenda. London: BMJ Books; 2002:108-32.
8. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th edition, text revision. Washington, DC: Author; 2000.
9. Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R, Ferguson D, D'Agostino R Jr. The Female Sexual Function Index (FSFI): A multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther 2000;26:191-208.
10. Wiegel M, Meston C, Rosen R. The Female Sexual Function Index: Cross-validation and development of clinical cut-off scores. J Sex Marital Ther 2005;31:1-20.
11. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th edition. Washington, DC: Author; 1994.
12. Spanier GB. Measuring dyadic adjustment: New scales for assessing the quality of marriage and similar dyads. J Marriage Fam 1976;38:15-28.
13. Locke HJ, Wallace KM. Short marital-adjustment and prediction tests: Their reliability and validity. Marriage Fam Living 1959;21:251-55.
14. Derogatis LR. SCL-90-R: Administration, scoring and procedures. Manual II. Towsen, MD: Clinical Psychometric Research; 1983.
15. Derogatis LR, Melisaratos N. The DSFI: A multidimensional measure of sexual functioning. J Sex Marital Ther 1979;5:244-81.
16. Derogatis LR, Melisaratos N. The Brief Symptom Inventory: An introductory report. Psychol Med 1983;13:595-605.
17. Dunlap WP, Cortina JM, Vaslow JB, Burke MJ. Meta-analysis of experiments with matched groups of repeated measures designs. Psychol Methods 1996;1:170-77.
18. McCall K, Meston CM. Cues resulting in desire for sexual activity in women. J Sex Med 2006;3:838-52.